Annual progress reports
Countries no longer submit annual progress reports. Please refer to the joint appraisal report and Multi-Stakeholder Dialogue documents on this page.
Annual progress report Niger 2004
Annual progress report Niger 2005 [Français]
Annual progress report Niger 2014
Annual progress report Niger 2003
Annual progress report Niger 2014 [Français]
Annual progress report Niger 2003 [Français]
Annual progress report Niger 2013
Annual progress report Niger 2002 [Francais]
Annual progress report Niger 2013 [Français]
Annual progress report Niger 2001 [Français]
Annual progress report Niger 2012
Annual progress report Niger 2011
Annual progress report Niger 2010
Annual progress report Niger 2009
Annual progress report Niger 2009 [Français]
Annual progress report Niger 2008
Annual progress report Niger 2008 [Français]
Annual progress report Niger 2007
Annual progress report Niger 2007 [Français]
Annual progress report Niger 2006 [Français]
The joint appraisal report and Multi-Stakeholder Dialogue
The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.
In 2020/2021, as a result of the COVID-19 pandemic, Multi-stakeholder dialogue (MSD) documents temporarily replaced the traditional Joint Appraisal to ensure that Gavi’s continuing support to the EPI programme be aligned with realities at country level.
Proposal for NVS - Measles follow-up campaign support 2019 - Niger [Français]
Proposal for NVS - Measles follow-up support 2019 - Niger
Proposal for CCEOP support - Niger
Proposal for NVS - MenA support: Niger
Proposal for NVS - MenA support: Niger [Français]
Proposal for NVS -MenA- mini catch-up campaign(2017-2020) - Niger
Proposal for NVS - IPV support: Niger
Proposal for NVS - IPV support: Niger [Français]
Proposal for HSS support 2014: Niger
Proposal for HSS support 2014: Niger [Français]
Proposal for HPV demo programme: Niger
Proposal for HPV demo programme: Niger [Français]
Proposal for NVS - PCV, Rota support: Niger
Proposal for NVS - PCV, Rota support: Niger [Français]
Proposal for HSS support: Niger
Proposal for HSS support: Niger [Français]
Proposal for NVS - YF support: Niger [Français]
Proposal for NVS - YF, Penta support: Niger
Proposal for ISS support: Niger
Proposal for ISS support: Niger [Français]
Proposal for INS support: Niger
Proposal for ISS support: Niger (2001)
Proposal for ISS support: Niger [Français](2)
Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy
The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives.
Country co-financing information sheet
The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.
Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.
The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).
Data quality audit
The DQA has been developed by WHO to help evaluate the quality of countries' health information systems and to verify the accuracy of reported data. Read more.
DQA 2003 [Français]
Decision Letters and Partnerships Agreement
The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.
COVAX Technical Assistance Plans
In September 2020, the Gavi Board approved resources from core funding to focus on urgent technical assistance (TA) needs for 92 AMC economies, for the planning and preparation for the introduction of the COVID-19 vaccine. The plan includes sets of activities, milestones and budget for a given year.
COVAX Technical Assistance Plan Niger 2021
Targeted country assistance plans
Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.